Literature DB >> 13784172

A synopsis of recent investigations of 6-azauridine (NSC-32074).

A D WELCH, R E HANDSCHUMACHER, S C FINCH, J J JAFFE, S S CARDOSO, P CALABRESI.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS/pharmacology; URACIL/related compounds

Mesh:

Substances:

Year:  1960        PMID: 13784172

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN: 0069-0112


× No keyword cloud information.
  6 in total

1.  The uricosuria and orotic aciduria induced by 6-azauridine.

Authors:  H J FALLON; E FREI; J BLOCK; J E SEEGMILLER
Journal:  J Clin Invest       Date:  1961-10       Impact factor: 14.808

2.  3-Deazauridine (NSC 126849): an interesting modulator of biochemical response.

Authors:  W J Moriconi; M Slavik; S Taylor
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

3.  6-Azauridine in brain tissue during chick embryonal development.

Authors:  J Grafnetterová; D Grafnetter
Journal:  Experientia       Date:  1968-01-15

4.  Hydrolysis of the prodrug, 2',3',5'-triacetyl-6-azauridine.

Authors:  C M Riley; M A Mummert; J Zhou; R L Schowen; D G Vander Velde; M D Morton; M Slavik
Journal:  Pharm Res       Date:  1995-09       Impact factor: 4.200

5.  THE DEMONSTRATION OF THE SITE OF ACTION OF THE ANTIMETABOLITE DRUG 6-AZAURIDINE BY THE USE OF LEUCOCYTE CULTURES.

Authors:  A S BUTTOO; M W ELVES; M C ISRAUELS; O S ROATH
Journal:  Br J Pharmacol Chemother       Date:  1964-08

6.  Pyrimidine metabolism in man. V. The measurement in vivo of the biochemical effect of antineoplastic agents in animal and human subjects.

Authors:  M T RABKIN; E W FREDERICK; M LOTZ; L H SMITH
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.